Pfizer (PFE)
(Real Time Quote from BATS)
$29.04 USD
-0.46 (-1.56%)
Updated Sep 25, 2024 03:01 PM ET
2-Buy of 5 2
B Value F Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Pfizer Inc. [PFE]
Reports for Purchase
Showing records 161 - 180 ( 577 total )
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 29.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 8122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 22.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
No Life Science Worries - Positive Reads
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 72122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 71122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 1.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 7122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended June 24.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Battling Covid - Vaccines, Prescription Treatments, and Supplements from Alpha (A) through Lambda (E)
Provider: Univest Securities, LLC
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 62122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
E.N.D.O - Exploring New Drug Opportunities in Endocrinology KOL Call Highlights
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 61122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended June 3.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 6122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department